Rodman & Renshaw maintained its Spectranetics SPNC Market Outperform rating and $9 price target in a research report published today.
In the report, Rodman & Renshaw states, "We are curious of what new strategic initiatives the new CEO will be embarking upon. To us, the next two quarterly calls will be very telling about the next leg up for this story."
Shares of Spectranetics were trading at $7.20 at the time of posting, up 9.76% from Wednesday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in